Press Release: Tecan to expand its Partnering Business with acquisition of Sias

Tecan Group AG / Tecan to expand its Partnering Business with acquisition of Sias . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

-- Sias, a leading OEM supplier of laboratory automation solutions, adding new platforms, capabilities and corporate clients to Tecan's broad portfolio

-- Sias to become part of Tecan's Partnering Business, leveraging Tecan's global sales infrastructure and after-sales support capabilities

-- Valuation representing a multiple of approximately one times expected fiscal year 2015 sales of Sias

-- Close proximity of Swiss facilities enables synergies and joint development of efficiencies

-- Transaction anticipated to be accretive to earnings per share before transaction-related amortization in 2017

Männedorf, Switzerland, October 28, 2015 - The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has reached agreement with the majority shareholders of Sias to acquire Sias AG, a leading OEM supplier of a wide range of modular and complete laboratory automation solutions. Sias will become a part of Tecan's Partnering Business, leveraging Tecan's global sales infrastructure and after-sales support capabilities. The acquisition adds further scale to Tecan's leading OEM business, brings new corporate customers in the in-vitro diagnostics segment and a healthy funnel of new development projects. Sias' modular platforms and robotic components are ideally suited for low- to medium-throughput applications and thus expand the range of Tecan's existing automation solutions and components offering.

The transaction is valued at approximately one times expected fiscal year 2015 sales of Sias of around CHF 25 million. The purchase consideration will be fully paid in cash. The transaction is expected to be accretive to earnings per share (EPS) before transaction-related amortization in 2017. Closing of the transaction is subject to certain conditions, including the timely transfer of sufficient shares.

Tecan CEO Dr. David Martyr commented: "We are pleased to have reached this agreement and look forward to welcoming the Sias team into Tecan. Sias will add further scale to our leading Partnering Business and provides access to complementary automation platforms which are particularly well suited as the basis for small to mid-size OEM systems for diagnostic as well as research applications."

Dr. Achim von Leoprechting, Head of Tecan's Partnering Business added: "Sias' core expertise in automating immunoassays and molecular diagnostics workflows as well as their strong client base in China perfectly match with our corporate strategy. In addition, the close proximity of the two Swiss facilities allows synergies to be implemented."

Andre Guenter, CEO of Sias, said: "We have reached a mutually beneficial agreement. We bring a dedicated, highly trained team, innovative technologies and leading products, a strong pipeline of new development projects and dedicated business partners all over the world. Tecan's global presence will allow us to grow even faster than our current rate by leveraging local sales and service organizations. We will greatly benefit from the combined capabilities of the larger development organization. It is a good opportunity for the shareholders of Sias AG to realize their loyal investment."

A leading OEM supplier of specialized automation solutions

Sias AG is a leading OEM supplier of a wide range of modular and all-inclusive laboratory automation solutions. The company is one of the world's leading manufacturers in the liquid handling segment. Sias was founded in Hombrechtikon, Zurich, in the year 2000. Since 2011, Sias further strengthened its position as an innovative OEM supplier, including through the acquisition of Xiril AG in 2012. The company has around 80 employees and supplies customers in Europe, the USA and China. Sias' customers are primarily in the diagnostics and research sectors.

Additional information can be found on the Sias webpage:

www.sias.biz

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2014, Tecan generated sales of CHF 400 million (USD 437 million; EUR 331 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:

Tecan Group

Martin Brändle

Vice President, Communications & Investor Relations

Tel. +41 (0) 44 922 84 30

Fax +41 (0) 44 922 88 89

investor@tecan.com

www.tecan.com

Press Release: http://hugin.info/100384/R/1961905/715460.pdf

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Tecan Group AG via Globenewswire

HUG#1961905

--- End of Message ---

Tecan Group AG

Seestrasse 103 Maennedorf Switzerland

ISIN: CH0012100191;

http://www.tecan.com (END) Dow Jones Newswires

   October 28, 2015 02:00 ET (06:00 GMT)- - 02 00 AM EDT 10-28-15